Data as of Dec 06
| -0.12 / -4.56%|
The 2 analysts offering 12-month price forecasts for CytRx Corp have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +178.88% increase from the last price of 2.51.
The current consensus among 2 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.